Cargando…

Can Macrolide Antibiotics Prevent Hospital Readmissions?

Detalles Bibliográficos
Autores principales:	Wedzicha, Jadwiga A., Ritchie, Andrew I., Martinez, Fernando J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812442/ https://www.ncbi.nlm.nih.gov/pubmed/31188635 http://dx.doi.org/10.1164/rccm.201905-0957ED

Ejemplares similares

Ending on a Crescendo: Reflections on Seven Years of a Successful Journal
por: Wedzicha, Jadwiga A., et al.
Publicado: (2021)

Is gastro-oesophageal reflux associated with COPD exacerbations?
por: Wedzicha, Jadwiga A.
Publicado: (2013)

Causes of Death in Smokers: Implications for Chronic Obstructive Pulmonary Disease Management across Disease Severity
por: Wedzicha, Jadwiga A.
Publicado: (2023)

Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Yang, Eun-Ae, et al.
Publicado: (2017)

Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations
por: Ritchie, Andrew I., et al.
Publicado: (2020)

The role of antibiotic prophylaxis after radical cystectomy in preventing urinary tract infections and readmission for sepsis
por: Martini, Alberto, et al.
Publicado: (2018)

Professor Gavin Donaldson. 1961–2023
por: Wedzicha, Jadwiga A., et al.
Publicado: (2023)

Association of Macrolide Resistance Genotypes and Synergistic Antibiotic Combinations for Combating Macrolide-Resistant MRSA Recovered from Hospitalized Patients
por: Bishr, Amr S., et al.
Publicado: (2021)

Deprivation, winter season, and COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Macrolide Therapy in Chronic Inflammatory Diseases
por: Asano, Kazuhito, et al.
Publicado: (2012)

A Platform for the Discovery of New Macrolide Antibiotics
por: Seiple, Ian B., et al.
Publicado: (2016)

The evolution of substrate discrimination in macrolide antibiotic resistance enzymes
por: Pawlowski, Andrew C., et al.
Publicado: (2018)

Macrolides for treatment of chronic obstructive pulmonary disease
por: Sun, Xue-Jiao, et al.
Publicado: (2019)

The immunomodulatory effects of macrolide antibiotics in respiratory disease
por: Pollock, Jennifer, et al.
Publicado: (2021)

Administration of macrolide antibiotics increases cardiovascular risk
por: Wu, Yang, et al.
Publicado: (2023)

COPD exacerbations: defining their cause and prevention
por: Wedzicha, Jadwiga A, et al.
Publicado: (2007)

Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention
por: Seemungal, Terence, et al.
Publicado: (2008)

Macrolides as Empiric Therapy for Outpatients With Pneumonia
por: Musher, Daniel M
Publicado: (2021)

Hospital Readmissions: New Pandemic, Same Old Problems?
por: Fancher, Kendall G., et al.
Publicado: (2021)

Preventing readmissions of COPD patients: more prospective studies are needed
por: Nuñez, Alexa, et al.
Publicado: (2020)

The Efficacy of Glucocorticoid on Macrolide Resistant Mycoplasma Pneumonia in Children
por: Oh, Jae-Won
Publicado: (2014)

Hospital Readmissions after Acute Coronary Syndromes
por: Mansur, Alfredo J.
Publicado: (2019)

C. acnes qPCR-Based Antibiotics Resistance Assay (ACQUIRE) Reveals Widespread Macrolide Resistance in Acne Patients and Can Eliminate Macrolide Misuse in Acne Treatment
por: Zhang, Jingheng, et al.
Publicado: (2022)

Drug Resistance Mechanisms of Mycoplasma pneumoniae to Macrolide Antibiotics
por: Liu, Xijie, et al.
Publicado: (2014)

Spectrophotometric Investigations of Macrolide Antibiotics: A Brief Review
por: Keskar, Mrudul R, et al.
Publicado: (2015)

Advanced Methods for Studying Structure and Interactions of Macrolide Antibiotics
por: Jednačak, Tomislav, et al.
Publicado: (2020)

Fate of Macrolide Antibiotics with Different Wastewater Treatment Technologies
por: Pan, Min, et al.
Publicado: (2021)

Context-specific action of macrolide antibiotics on the eukaryotic ribosome
por: Svetlov, Maxim S., et al.
Publicado: (2021)

Mechanisms of Resistance to Macrolide Antibiotics among Staphylococcus aureus
por: Miklasińska-Majdanik, Maria
Publicado: (2021)

A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy
por: Keelan, Jeffrey A., et al.
Publicado: (2016)

Autoinducer Analogs Can Provide Bactericidal Activity to Macrolides in Pseudomonas aeruginosa through Antibiotic Tolerance Reduction
por: Abe, Mizuki, et al.
Publicado: (2021)

Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics
por: Steel, Helen C., et al.
Publicado: (2012)

Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review
por: Hurst, John R, et al.
Publicado: (2009)

Predicting and preventing hospital readmission for exacerbations of COPD
por: Kong, Chia Wei, et al.
Publicado: (2020)

Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis
por: Ebhohon, Ebehiwele, et al.
Publicado: (2021)

Current status and inspiration on macrolides in the treatment of chronic obstructive pulmonary disease
por: Qiu, Shi-lin, et al.
Publicado: (2015)

Bioassay-Guided Evolution of Glycosylated Macrolide Antibiotics in Escherichia coli
por: Lee, Ho Young, et al.
Publicado: (2007)

Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients
por: Ma, Terry King-Wing, et al.
Publicado: (2014)

Research on the treatment of Pseudomonas aeruginosa pneumonia in children by macrolide antibiotics
por: Huang, Xu-qiang, et al.
Publicado: (2015)

Nature nurtures the design of new semi-synthetic macrolide antibiotics
por: Fernandes, Prabhavathi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fviogsmeeg3t1gvmrcrt843shj